1 |
AR
💬
| 4件: Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | Oxandrolone
Oxandrolone
💬
|
Oxandrolone
| 2件: 211 211, 285 💬
|
2 |
EDNRA
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | Ambrisentan
Ambrisentan
💬
|
Ambrisentan
| 8件: 51 51, 66, 84, 85, 86, 88, 210, 211 💬
|
3 |
EDNRA
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
4 |
EDNRA
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
5 |
EDNRB
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
6 |
EDNRB
💬
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | Bosentan
Bosentan
💬
|
Bosentan
| 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
7 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone acetate
Methylprednisolone acetate
💬
|
Methylprednisolone
| 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
8 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone
Methylprednisolone
💬
|
Methylprednisolone
| 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
9 |
PDE5
💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway | Sildenafil
Sildenafil
💬
|
Sildenafil
| 14件: 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|
10 |
PDE5
💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway | Sildenafil citrate
Sildenafil citrate
💬
|
Sildenafil
| 14件: 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|